Overview

Assessing Symptomatic Clinical Episodes in Depression

Status:
Completed
Trial end date:
2019-01-07
Target enrollment:
Participant gender:
Summary
Randomized, Double-Blind, Active-Controlled Study of AXS-05 for MDD.
Phase:
Phase 2
Details
Lead Sponsor:
Axsome Therapeutics, Inc.
Treatments:
Bupropion